Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-transplant Events

NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT

Abstract

Bronchiolitis obliterans syndrome (BOS) is a serious complication of chronic GVHD (cGVHD) following HSCT (hematopoietic SCT). The clinical diagnosis of BOS is based on pulmonary function test (PFT) abnormalities including: FEV1<75% predicted and obstructive FEV1/VC ratio, calculated using reference equations. We sought to determine if the frequency of clinical diagnoses and severity of BOS would be altered by using the recommended NHANES III vs older equations (Morris/Goldman/Bates, MGB) in 166 cGVHD patients, median age 48 (range: 12–67). We found that NHANES III equations significantly increased the prevalence of BOS, with an additional 11% (18/166) meeting diagnostic criteria by revealing low FEV1 (<75%) (P<0.0001), and six additional patients by obstructive ratio (vs MBG). Collectively, this led to an increase of BOS incidence from 17 (29/166) to 29% (41/166). For patients with severe BOS, (FEV1<35%), NHANES III equations correctly predicted death 71.4% vs 50% using MGB. In conclusion, the use of NHANES III equations markedly increases the proportion of cases meeting diagnostic criteria for BOS and improves prediction of survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Williams KM, Chien JW, Gladwin MT, Pavletic SZ . Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Jama 2009; 302: 306–314.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Clark JG, Crawford SW, Madtes DK, Sullivan KM . Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368–376.

    Article  CAS  PubMed  Google Scholar 

  3. Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ . Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9: 657–666.

    Article  PubMed  Google Scholar 

  4. Nishio N, Yagasaki H, Takahashi Y, Muramatsu H, Hama A, Tanaka M et al. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children. Bone Marrow Transplant 2009; 44: 303–308.

    CAS  PubMed  Google Scholar 

  5. Santo Tomas LH, Loberiza FR Jr, Klein JP, Layde PM, Lipchik RJ, Rizzo JD et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005; 128: 153–161.

    Article  PubMed  Google Scholar 

  6. Au BK, Au MA, Chien JW . Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010; 17: 1072–1078.

    Article  PubMed  PubMed Central  Google Scholar 

  7. White DA, Wong PW, Downey R . The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2000; 161 (3 Pt 1): 723–729.

    Article  CAS  PubMed  Google Scholar 

  8. Suzuki T, Saijo Y, Ebina M, Yaekashiwa M, Minegishi M, Tsuchiya S et al. Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 829–831.

    Article  CAS  PubMed  Google Scholar 

  9. Chadwick C, Marven SM, Vora AJ . Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans. Bone Marrow Transplant 2004; 33: 451–453.

    Article  CAS  PubMed  Google Scholar 

  10. Kumar S, Tefferi A . Spontaneous pneumomediastinum and subcutaneous emphysema complicating bronchiolitis obliterans after allogeneic bone marrow transplantation—case report and review of literature. Ann Hematol 2001; 80: 430–435.

    Article  CAS  PubMed  Google Scholar 

  11. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12: 138–151.

    Article  PubMed  Google Scholar 

  12. Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208–214.

    Article  PubMed  Google Scholar 

  13. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12: 252–266.

    Article  PubMed  Google Scholar 

  14. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  PubMed  Google Scholar 

  15. Chien JW, Duncan S, Williams KM, Pavletic SZ . Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16 (1 Suppl): S106–S114.

    Article  PubMed  Google Scholar 

  16. Gunn ML, Godwin JD, Kanne JP, Flowers ME, Chien JW, High-resolution CT . findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 2008; 23: 244–250.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hankinson JL, Odencrantz JR, Fedan KB . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179–187.

    Article  CAS  PubMed  Google Scholar 

  18. Roberts CM, MacRae KD, Winning AJ, Adams L, Seed WA . Reference values and prediction equations for normal lung function in a non-smoking white urban population. Thorax 1991; 46: 643–650.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Collen J, Greenburg D, Holley A, King C, Roop S, Hnatiuk O . Racial discordance in spirometry comparing four commonly used reference equations to the National Health and Nutrition Examination Study III. Respir Med 2010; 104: 705–711.

    Article  PubMed  Google Scholar 

  20. Collen J, Greenburg D, Holley A, King CS, Hnatiuk O . Discordance in spirometric interpretations using three commonly used reference equations vs national health and nutrition examination study III. Chest 2008; 134: 1009–1016.

    Article  PubMed  Google Scholar 

  21. Society AT . Lung Function Testing: Selection of Reference values and interpretative strategies. American Thoracic Society 1991 Contract No. 1202, 144: 1202–1218.

    Google Scholar 

  22. Hansen JE, Sun XG, Wasserman K . Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not&lt;70%. Chest 2007; 131: 349–355.

    Article  PubMed  Google Scholar 

  23. Baird K, Steinberg SM, Grkovic L, Pulanic D, Cowen EW, Mitchell SA et al. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. Biol Blood Marrow Transplant 2013; 19: 632–639.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW et al. Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia 2012; 26: 633–643.

    Article  CAS  PubMed  Google Scholar 

  25. Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM et al. Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood 2011; 118: 4250–4257.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Lim S, MacRae KD, Seed WA, Roberts CM . The value of forced expiratory volume in 1 s in screening subjects with stable COPD for PaO2&lt;7.3 kPa qualifying for long-term oxygen therapy. Respir Med 1998; 92: 1122–1126.

    Article  CAS  PubMed  Google Scholar 

  27. Gassas A, Craig-Barnes H, Dell S, Doyle J, Schechter T, Sung L et al. Chest health surveillance utility in the early detection of bronchiolitis obliterans syndrome in children after allo-SCT. Bone Marrow Transplant 2013; 48: 814–818.

    Article  CAS  PubMed  Google Scholar 

  28. Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P . Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 2000; 161: 1924–1929.

    Article  CAS  PubMed  Google Scholar 

  29. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968.

    Article  CAS  PubMed  Google Scholar 

  30. Hildebrandt GC, Fazekas T, Lawitschka A, Bertz H, Greinix H, Halter J et al. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 2011; 46: 1283–1295.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Bacigalupo A, Chien J, Barisione G, Pavletic S . Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment. Semin Hematol 2012; 49: 15–24.

    Article  PubMed  Google Scholar 

  32. Uhlving HH, Buchvald F, Heilmann CJ, Nielsen KG, Gormsen M, Muller KG . Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transplant 2012; 47: 1020–1029.

    Article  CAS  PubMed  Google Scholar 

  33. Lam DC, Lam B, Wong MK, Lu C, Au WY, Tse EW et al. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT—a randomized double-blinded placebo-controlled study. Bone Marrow Transplant 2011; 46: 1551–1556.

    Article  CAS  PubMed  Google Scholar 

  34. Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T et al. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. Transplant Int 2013; 26: 631–639.

    Article  Google Scholar 

  35. Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T et al. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transplant 2013; 48: 819–824.

    Article  CAS  PubMed  Google Scholar 

  36. Hostettler KE, Halter JP, Gerull S, Lardinois D, Savic S, Roth M et al. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. Eur Respir J, (e-pub ahead of print 3 May 2013).

  37. Duarte RF, Greinix H, Rabin B, Mitchell SA, Basak G, Wolff D et al. Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force. Bone Marrow Transplant 2014; 49: 49–54.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge Dr David Jacobsohn for his thorough review of this manuscript. National Institutes of Health intramural funds supported this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K M Williams.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, K., Hnatiuk, O., Mitchell, S. et al. NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT. Bone Marrow Transplant 49, 561–566 (2014). https://doi.org/10.1038/bmt.2013.222

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.222

Keywords

This article is cited by

Search

Quick links